                </a></li></ul></div><p><strong>Figure 3.  <span>Conditional inactivation of <em>Mib1</em> in endothelial cells generates a <em>Dll4</em> mutant phenotype.</span></strong></p><a id="article1.body1.sec2.sec5.fig1.caption1.p1" name="article1.body1.sec2.sec5.fig1.caption1.p1"></a><p>(A, B) External view of embryonic day 9.5 (E9.5) yolk sacs (A) and embryos (B). The <em>Tie2-cre;Mib1<sup>f/f</sup></em> yolk sac (A, right) has failed to remodel the primary vascular plexus to form large vitelline blood vessels. The <em>Tie2-cre;Mib1<sup>f/f</sup></em> embryo (B, right) exhibits growth retardation and pericardial effusion. (C–F) Whole-mount PECAM staining of E9.5 <em>wild-type</em> (C, E) and <em>Tie2-cre;Mib1<sup>f/f</sup></em> (D, F) embryos. The large cranial vessels appear truncated and degenerated in the mutants (D, arrows). Intersomitic vessels are present, but the angiogenic sprouts are disorganized in the mutants (F). (G, H) Sections of PECAM-1 stained embryos. The dorsal aortas of <em>Tie2-cre;Mib1<sup>f/f</sup></em> embryos are reduced in diameter (H). ACV, anterior cardinal vein; DA, dorsal aorta. Scale bar, 200 µm. (I–L) Sections of <em>ephrinB2</em> (I,J) and CD44 (K,L) stained embryos. The dorsal aortas of <em>Tie2-cre;Mib1<sup>f/f</sup></em> (J,L) embryos are negative for the arterial markers, <em>ephrinB2</em> and CD44. (M–P) Sections of <em>sm22</em> (M,N) and αSMA (O,P) stained embryos. The smooth muscle cell markers, <em>sm22</em> and αSMA, are lost in the dorsal aortas of <em>Tie2-cre;Mib1<sup>f/f</sup></em> embryos (N,P). (Q) Semiquantitative RT-PCR in the yolk sac (ys) and para-aortic splenchnopleura (P-Sp) of <em>wild-type</em> (wt) and <em>Tie2-cre;Mib1<sup>f/f</sup></em> (mt). <em>Hey1</em> is down-regulated in the mt yolk sac (left panel). <em>Dll4</em> expression in the mt P-Sp is similar to that of wt (right panel). <em>β-actin</em> was used for normalization.</p>
